German Atrial Fibrillation Network   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Münster Germany (2003)

Organization Overview

First Clinical Trial
2005
NCT00098137
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now